Merck KGaA (MKGAF)
158.20
+2.05
(+1.31%)
USD |
OTCM |
Jun 10, 16:00
Merck Market Cap : 68.78B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 68.78B |
| June 09, 2026 | 67.89B |
| June 08, 2026 | 69.44B |
| June 05, 2026 | 71.21B |
| June 04, 2026 | 71.18B |
| June 03, 2026 | 64.86B |
| June 02, 2026 | 66.92B |
| June 01, 2026 | 67.18B |
| May 29, 2026 | 67.26B |
| May 28, 2026 | 66.83B |
| May 27, 2026 | 66.14B |
| May 26, 2026 | 67.58B |
| May 22, 2026 | 65.80B |
| May 21, 2026 | 64.87B |
| May 20, 2026 | 62.17B |
| May 19, 2026 | 61.18B |
| May 18, 2026 | 60.80B |
| May 15, 2026 | 62.13B |
| May 14, 2026 | 62.17B |
| May 13, 2026 | 64.13B |
| May 12, 2026 | 57.61B |
| May 11, 2026 | 58.48B |
| May 08, 2026 | 58.35B |
| May 07, 2026 | 58.51B |
| May 06, 2026 | 59.00B |
| Date | Value |
|---|---|
| May 05, 2026 | 57.23B |
| May 04, 2026 | 57.67B |
| May 01, 2026 | 57.02B |
| April 30, 2026 | 57.74B |
| April 29, 2026 | 55.70B |
| April 28, 2026 | 58.20B |
| April 27, 2026 | 56.83B |
| April 24, 2026 | 57.38B |
| April 23, 2026 | 56.85B |
| April 22, 2026 | 59.96B |
| April 21, 2026 | 62.30B |
| April 20, 2026 | 60.63B |
| April 17, 2026 | 60.22B |
| April 16, 2026 | 59.96B |
| April 15, 2026 | 60.61B |
| April 14, 2026 | 58.16B |
| April 13, 2026 | 56.23B |
| April 10, 2026 | 59.22B |
| April 09, 2026 | 59.29B |
| April 08, 2026 | 55.72B |
| April 07, 2026 | 56.16B |
| April 06, 2026 | 53.45B |
| April 02, 2026 | 55.70B |
| April 01, 2026 | 53.86B |
| March 31, 2026 | 53.24B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bayer AG | 39.93B |
| Dermapharm Holding SE | 3.177B |
| Takeda Pharmaceutical Co., Ltd. | 49.54B |
| AstraZeneca PLC | 555.07B |
| Veru, Inc. | 47.35M |
Market Cap Related Metrics
| PE Ratio | 23.43 |
| PS Ratio | 2.832 |
| Price to Book Value | 2.007 |
| Price to Free Cash Flow | 179.68 |
| Price | 158.20 |
| Earnings Yield | 4.27% |
| Operating PE Ratio | 14.59 |
| Normalized PE Ratio | 21.16 |